I think it’s time for a little honesty. Not every stock I currently favor is performing well. Still, I lean towards companies that are fundamentally strong and I believe will recover when the moment is right.
A clear example of this is during the COVID-19 pandemic, which, let’s face it, restricted travel for pretty much everyone. This hit the airline and cruise sectors especially hard. Yet, both Delta Air Lines and Royal Caribbean Cruises managed to turn a significant profit just a year later, even after facing such bleak circumstances.
On a related note, I also see promise in UnitedHealth Group (NYSE:UNH). Last year, it struggled with disappointing results and couldn’t hold onto strong profit margins. However, the company seems poised for a rebound, especially after some recent announcements which have sparked optimism about potential returns in the near future.
It’s worth noting that UnitedHealth Group’s stock has dropped 41% over the past year, and there’s a solid reason for that. Early signs of trouble appeared in 2025 when it first missed profit estimates since the 2008-09 financial crisis. There were also increased costs associated with their members, leading to revisions in their annual outlook.
Additionally, there have been complications involving the Medicare Advantage Program, which, though popular as a private alternative to the federal Medicare, has added to some of UnitedHealth’s challenges. These included a Justice Department investigation into billing practices, the CEO resigning, and there were even unfortunate events like the tragic murder of an executive in New York City.
Recently, UnitedHealth announced plans to cut back on its Medicare Advantage offerings across 16 states. Yet, there’s been a much-needed uplift. The Trump administration has approved higher-than-expected payment rates for these plans, which could enhance profitability for health insurers like UnitedHealth.
The government aims to increase payments by 2.48% in 2027, a notable shift from an earlier proposed increase of just 0.09%. This change can have a dual effect: it encourages companies like UnitedHealth to expand their Medicare Advantage programs, and it improves profit margins by offsetting rising medical costs.
UnitedHealth has traditionally been a solid dividend stock, currently offering a 2.9% yield. But the recent decline in stock prices isn’t really about dividends; it’s mainly connected to earnings expectations. Back in January, management suggested that revenues for 2025 might hit a minimum of $439 billion, rising from $337.6 billion, and profits were projected to grow as well.
Now that payment rates for Medicare Advantage are on the rise, many will be watching UnitedHealth’s upcoming earnings report on April 21st closely. If the management talks about possibly re-entering markets from which they’ve previously exited, I think that would signal a strong recovery.
Before investing in UnitedHealth Group, it’s essential to consider various factors.
According to Motley Fool Stock Advisor, their analysts have identified what they consider to be some of the 10 best stocks available right now, and ironically, UnitedHealth Group isn’t included in that lineup. These identified stocks are projected to yield notable returns over the next few years.
It’s interesting to look back at stocks like Netflix. If you had invested $1,000 when it was first recommended in 2004, you would now have around $555,526! Similarly, Nvidia has seen remarkable gains; a $1,000 investment at its recommendation point in 2005 has ballooned to about $1,156,403!
Overall, it’s essential to remember that the Stock Advisor program boasts an impressive average return of 968%, which far surpasses the S&P 500’s 191%—a significant market outperformance. This is a moment not to overlook if you’re considering investments.
